SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-015261
Filing Date
2022-05-27
Accepted
2022-05-27 10:35:15
Documents
1
Period of Report
2021-12-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3167
  Complete submission text file 0001493152-22-015261.txt   4649
Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609 NEW YORK NY 10170
Business Address
Shailubhai Kunwar (Reporting) CIK: 0001307746 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-56257 | Film No.: 22973574

Mailing Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001
Business Address 5 PENN PLAZA, 19TH FLOOR #1954 NEW YORK NY 10001 442070661000
Accustem Sciences Inc. (Issuer) CIK: 0001850767 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations